EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas

Francesco D'Alò iD, Silvia Bellesi, Elena Maiolo, Eleonora Alma, Flaminia Bellisario iD, Rosalia Malafronte, Marcello Viscovo iD, Fabrizia Campana, Stefan Hohaus iD

Cancers · 17.06.2024 · 16 (12) · 2243

DOI: 10.3390/cancers16122243 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 17.06.2024. Verfasst von Francesco D'Alò und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, 00168 Rome, Italy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Piano nazionale ripresa resilienza.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the introduction of rituximab in the late 1990s, significant progress has been made in advancing targeted therapies for B cell lymphomas, improving patients’ chance of being cured and clinicians’ therapeutic armamentarium. A better understanding of disease biology and pathogenic pathways, coupled with refinements in immunophenotypic and molecular diagnostics, have been instrumental in these achievements. While traditional chemotherapy remains fundamental in most cases, concerns surrounding chemorefractoriness and cumulative toxicities, particularly the depletion of the hemopoietic reserve, underscore the imperative for personalized treatment approaches. Integrating targeted agents, notably monoclonal antibodies, alongside chemotherapy has yielded heightened response rates and prolonged survival. A notable paradigm shift is underway with innovative-targeted therapies replacing cytotoxic drugs, challenging conventional salvage strategies like stem cell transplantation. This review examines the landscape of emerging targets for lymphoma cells and explores innovative therapies for diffuse large B cell lymphoma (DLBCL). From Chimeric Antigen Receptor-T cells to more potent monoclonal antibodies, antibody–drug conjugates, bispecific antibodies, checkpoint inhibitors, and small molecules targeting intracellular pathways, each modality offers promising avenues for therapeutic advancement. This review aims to furnish insights into their potential implications for the future of DLBCL treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

BCL2-inhibitorsBTK-inhibitorsXPO1-inhibitorsantibody–drug conjugatesbispecific antibodiescheckpoint inhibitorschimeric antigen receptor-T cellsdiffuse large B cell lymphoma

Autor:innen und Institutionen

  • Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • UOSD Malattie Linfoproliferative Extramidollari, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
  • UOC Servizio e DH di Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.

ORCID-Profile: Francesco D'Alò, Flaminia Bellisario, Marcello Viscovo, Stefan Hohaus

Förderung

  • Piano nazionale ripresa resilienza

Zitieren

APA

D'Alò, F., Bellesi, S., Maiolo, E., Alma, E., Bellisario, F., Malafronte, R., Viscovo, M., Campana, F., & Hohaus, S. (2024). Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas. Cancers, 16(12), 2243. https://doi.org/10.3390/cancers16122243

Vancouver

D'Alò F, Bellesi S, Maiolo E, Alma E, Bellisario F, Malafronte R, et al. Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas. Cancers. 2024;16(12):2243. doi:10.3390/cancers16122243

BibTeX
@article{DAl2024,
  author = {D'Alò, Francesco and Bellesi, Silvia and Maiolo, Elena and Alma, Eleonora and Bellisario, Flaminia and Malafronte, Rosalia and Viscovo, Marcello and Campana, Fabrizia and Hohaus, Stefan},
  title = {Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {12},
  pages = {2243},
  doi = {10.3390/cancers16122243}
}
Kostenlos starten →